de-speciated equine immunoglobulins (Integrated BioTherapeutics/Emergent BioSolutions)

N/A

Report date: 2025/06/11 10:44:44

Base Information

Drug Namede-speciated equine immunoglobulins (Integrated BioTherapeutics/Emergent BioSolutions)
Drug Alias NamePan-Ebolaanti-GP F(ab')2 (Integrated BioTherapeutics/Emergent)NP-026FILOV
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Polyclonal antibodies
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsFiloviridae InfectionsMarburg Virus DiseaseHemorrhagic Fever, Ebola
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIntegrated Biotherapeutics
China Registration ClassN/A

Develop Information

Active CompaniesEmergent Biosolutions Inc
Inactive CompaniesIntegrated Biotherapeutics
Active IndicationsFiloviridae InfectionsMarburg Virus DiseaseHemorrhagic Fever, Ebola
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A